期刊文献+

HERV参与肿瘤发生的研究进展 被引量:2

Research progress of HERV in tumorigenesis
下载PDF
导出
摘要 人类内源性逆转录病毒(human endogenous retrovirus,HERV)是外源型逆转录病毒侵入并整合人类基因组中的残余物。HERV及长末端段重复序列(LTR)约占了整个基因组的8%。HERV的遗传不稳定性使HERV在基因组中分布广泛,HERV LTR的结构特性可以诱发产生新的基因、调节病毒的编码基因与相邻宿主基因的异常表达。而病毒基因的功能及相邻的肿瘤基因的异常表达是肿瘤发生的重要因素。本文从HERV的起源、结构、分布出发探讨HERV参与肿瘤病理发生的现状及分子机制。 Human endogenous retrovirus (HERV) is known as the residue of exogenous retrovirus during the integration in the human genome. HERV and long terminal repeat constitute 8 % of the human genome. HERV is widely distributed in the human genome owing to its genetic instability. The feature of HERV LTR can induce the initial transcription of new genes and regulate the expression of viral gene and adjacent host gene. Overexpression of viral protein and LTR-associated oncogene are vital factors for tumorigenesis. In this review, we examined the origin,structure, distribution of HERV to investigate the molecular mechanism of HERV in tumor pathology process.
作者 于红莲
出处 《济宁医学院学报》 2015年第4期238-242,共5页 Journal of Jining Medical University
关键词 人内源性逆转录病毒 长末端重复序列 肿瘤发生 遗传不稳定性 Human endogenous retrovirus Long terminal repeat Tumorigenesis Genetic instability
  • 相关文献

参考文献20

  • 1Suntsova M, Garazha A, Ivanova A, et al. Molecular functions of human endogenous retroviruses in health and disease[J].Cell Mol Life Sci, 2015 ,Jun 18. [-Epub ahead of print]. 被引量:1
  • 2Rycaj K,Plummer J B, Yin B, et al. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells[J]. Clin Cancer Res, 2015,21 (2) : 471- 483. 被引量:1
  • 3Li S,Liu Z C,Yin S J,et al. Human endogenous retrovirus W family envelope gene activates the small conductance Ca (2 ~-)-activated K ~ channel in human neuroblastoma cells through CREB[J]. Neuroscience,2013,247: 164-174. 被引量:1
  • 4Nisbet-Brown E, Wegmann TG. Is acquired immunological tolerance genetically transmissible? [J]. Proc Natl Acad Sci U S A,1981,78(9) :5826-5828. 被引量:1
  • 5Yu H L, Zhao Z K , Zhu F. The role of human endogenous retrovirus long terminal repeat in human cancer[J]. Int J Mol Med, 2013,32(4):755-762. 被引量:1
  • 6Cegolon L, Salata C,Weiderpass E, et al. Human endogenous retroviruses and cancer prevention~ evidence and prospects [J]. BMC Cancer, 2013,13 : 4. 被引量:1
  • 7Lokossou A G, Toudic C, Barbeau B. Implication of human endogenous retrovirus envelope proteins in placental func-tions[J].Viruses ,2014,6(11) :4609-4627. 被引量:1
  • 8Holder B S,Tower C L, Abrahams V M, et al. Syncytin 1 in the human placenta[J]. Placenta, 2012,33 (6) : 460-466. 被引量:1
  • 9Medstrand P, Landry J R and Mager DL. Long terminal re- peats are used as alternative promoters for the endothelin B receptor and apolipoprotein C-I genes in humans[J].J Biol Chem,2001,276(3) : 1896-1903. 被引量:1
  • 10Zhao R,Chinai J M,Buhl S,et al. HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function [J].ProcNatlAcadSeiUSA,2013,110(24):9879-9884. 被引量:1

同被引文献28

  • 1况守龙,胡廷章.启动子的克隆和研究方法[J].重庆工学院学报,2007,21(1):136-139. 被引量:12
  • 2Mader M M,Henry J R.Antimetabolites,Comprehensive Medicinal Chemistry(11),[M].2007,Volume 7,55-79. 被引量:1
  • 3Magge R S,Deangelis L M.The double-edged sword: Neurotoxicity of chemotherapy[J].Blood Rev,2015,29(2):93-100.DOI:10.1016/j.blre.2014.09.012. 被引量:1
  • 4Van Den Neste E,Van Den Berghe G,Bontemps F.AI- CA-riboside(acadesine),an activator of AMP-activated protein kinase with potential for application in hemato- logic malignancies[J].Expert Opin Investig Drugs,2010,19(4):571-578.DOI:10.1517/13543781003703694. 被引量:1
  • 5Zeidler J,Baraniak D,Ostrowski T.Bioactive nucleoside analogues possessing selected five-membered azahetero- cyclic bases[J].Eur J Med Chem,2015,97(5):409-418.DOI:10.1016/j.ejmech.2014.11.057. 被引量:1
  • 6Musto P,Maurillo L,Spagnoli A A,et al.Azacitidine for the treatment of lower risk myelodysplastic syndromes [J].Cancer,2010,116(6):1485-1494.DOI:10.1002/ cncr.24894. 被引量:1
  • 7Momparler R L,C6t6 S,Momparler L F.Epigenetic ac- tion of decitabine(5-aza-2-deoxycytidine)is more ef- fective against acute myeloid leukemia than cytotoxic ac- tion of cytarabine(ARA-C)[J].Leuk Res,2013,37(8):980-984.DOI:10.1016/j.leukres.2013.04.019. 被引量:1
  • 8Reese N D,Schiller G J.High-dose cytarabine(HD araC)in the treatment of leukemias:a review[J].Curr Hematol Malig Rep,2013,8(2):141-148.DOI:10.1007/sl 1899-013-0156-3. 被引量:1
  • 9Ogura M,Tsukasaki K,Nagai H,et al.Phase I study of BCXl 777(forodesine)in patients with relapsed or re- fractory peripheral T/natural killer-cell malignancies [J].Cancer Sci,2012,103(7):1290-1295.DOI:10.1111/j.1349-7006.2012.02287. 被引量:1
  • 10Waud W R,Gilbert K S,Secrist J A.Preclinical antitu- mor activity of thiarabine in human leukemia and lym- phoma xenograft models[J].Nucleosides Nucleotides Nucleic Acids,2012,31(9):647-660.DOI:10.1080/15257770.2012.710768. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部